Neerja Sethi
Nurse Practitioner · Gilbert, AZNPI 1649390709
Payments from drug & device makers
Across 302 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$619
- AstraZeneca$593
- Pfizer$480
- GSK$392
- Lilly USA, LLC$283
- plus $2K from 37 others
What the payments were for
- Food & beverage$5,583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,583 in reported general payments places this provider in the 90th percentile of 1,719 nurse practitioner providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 169 | $199,422 |
| MounjaroTirzepatide | 26 | $31,989 |
| TrulicityDulaglutide | 20 | $22,564 |
| JanuviaSitagliptin Phosphate | 15 | $18,006 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 24 | $16,994 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $9,573 |
| MyrbetriqMirabegron | 16 | $8,321 |
| Repatha SureclickEvolocumab | 14 | $7,575 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $7,277 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $5,461 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $4,663 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $3,805 |
| Levothyroxine Sodium | 342 | $3,162 |
| SynthroidLevothyroxine Sodium | 32 | $2,913 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,650 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $619 | $199,422169 claims |
| Lilly USA, LLCMounjaro, Trulicity | $283 | $54,55346 claims |
| MerckJanuvia, Janumet Xr | $145 | $35,00039 claims |
| Astellas Pharma US IncMyrbetriq | $140 | $8,32116 claims |
| AstraZenecaSymbicort | $593 | $4,66317 claims |
| GSKBreo Ellipta | $392 | $3,80511 claims |
| AbbVieSynthroid | $1,099 | $2,91332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,719 nurse practitioner providers in Arizona.
Other nurse practitioner in Gilbert
- Sarah BlankenheimerGilbert$14K
- Ann MooreGlendale$2.1M
- Andrea KesslerLitchfield Park$780K
- Sandra KurtinTucson$201K
- Kristen HerzogScottsdale$162K
- Krista ArredondoChandler$133K
- Shannon MorgensternOro Valley$71K
- Helena In't VeldPhoenix$64K
- Steven KalfusChandler$43K
- Dustin NickersonPhoenix$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.